AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Traws Pharma, Inc. Director's Dealing 2013

Nov 19, 2013

35199_dirs_2013-11-18_1e892f13-e26b-4ff9-908d-50caeaefea89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-15

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-15	Common Stock	P	5000	$11.95	Acquired	4292800	Indirect
2013-11-15	Common Stock	P	5000	$11.99	Acquired	4297800	Indirect
2013-11-15	Common Stock	P	1900	$12.21	Acquired	4299700	Indirect
2013-11-15	Common Stock	P	7800	$11.97	Acquired	4307500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	84530	Indirect

Footnotes

F1: These shares are held in trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.